Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 609019, 8 pages
http://dx.doi.org/10.1155/2013/609019
Research Article

Mild Systemic Oxidative Stress in the Subclinical Stage of Alzheimer’s Disease

1Instituto de Química, USP, Cidade Universitária, Avenida Lineu Prestes 748, 05508-900 São Paulo, SP, Brazil
2Instituto de Ciências Ambientais, Química e Farmacêuticas, UNIFESP, Rua Arthur Riedel 275, 09972-270 Diadema, SP, Brazil
3Departamento de Hematologia e Oncologia, FMABC, Avenida Príncipe de Gales 821, 09060-650 Santo André, SP, Brazil
4Departamento de Medicina, UNIFESP, Rua Sena Madureira 1500, 04021-001 São Paulo, SP, Brazil
5Departamento de Medicina Preventiva, UNIFESP, Rua Sena Madureira 1500, 04021-001 São Paulo, SP, Brazil

Received 14 July 2013; Accepted 8 November 2013

Academic Editor: Sara Mostafalou

Copyright © 2013 Leandro Giavarotti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. C. Dickerson, A. Bakkour, D. H. Salat et al., “The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals,” Cerebral Cortex, vol. 19, no. 3, pp. 497–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jana and K. Pahan, “Fibrillar amyloid-β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase: Implications for Alzheimer's disease,” Journal of Biological Chemistry, vol. 279, no. 49, pp. 51451–51459, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. E. Finch and T. E. Morgan, “Inflammatory processes of Alzheimer disease and aging,” Proceedings of the Indian National Science Academy B, vol. 69, pp. 165–178, 2003. View at Google Scholar
  4. E. Zotova, J. A. Nicoll, R. Kalaria, C. Holmes, and D. Boche, “Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy,” Alzheimer's Research and Therapy, vol. 2, no. 1, article 1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. E. Rojo, J. A. Fernández, A. A. Maccioni, J. M. Jimenez, and R. B. Maccioni, “Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease,” Archives of Medical Research, vol. 39, no. 1, pp. 1–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Jomova, D. Vondrakova, M. Lawson, and M. Valko, “Metals, oxidative stress and neurodegenerative disorders,” Molecular and Cellular Biochemistry, vol. 345, no. 1-2, pp. 91–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. V. B. C. Junqueira, S. B. M. Barros, S. S. Chan et al., “Aging and oxidative stress,” Molecular Aspects of Medicine, vol. 25, no. 1-2, pp. 5–16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “Mini-mental state A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar
  9. J. C. Morris, “The Clinical Dementia Rating (CDR): current version and scoring rules,” Neurology, vol. 43, no. 11, pp. 2412–2414, 1993. View at Google Scholar · View at Scopus
  10. M. B. M. Montaño and L. R. Ramos, “Validity of the Portuguese version of Clinical Dementia Rating,” Revista de Saúde Pública, vol. 39, no. 6, pp. 912–917, 2005. View at Google Scholar
  11. F. Tietze, “Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues,” Analytical Biochemistry, vol. 27, no. 3, pp. 502–522, 1969. View at Google Scholar · View at Scopus
  12. H. Buss, T. P. Chan, K. B. Sluis, N. B. Domigan, and C. C. Winterbourn, “Protein carbonyl measurement by a sensitive ELISA method,” Free Radical Biology and Medicine, vol. 23, no. 3, pp. 361–366, 1998. View at Publisher · View at Google Scholar
  13. M. K. C. Brunialti, E. G. Kallás, M. Freudenberg, C. Galanos, and R. Salomão, “Influence of EDTA and heparin on lipopolysaccharide binding and cell activation, evaluated at single-cell level in whole blood,” Clinical Cytometry, vol. 50, no. 1, pp. 14–18, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Hasui, Y. Hirabayashi, and Y. Kobayashi, “Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood,” Journal of Immunological Methods, vol. 117, no. 1, pp. 53–58, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Wegiel, H. Imaki, K.-C. Wang et al., “Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice,” Acta Neuropathologica, vol. 105, no. 4, pp. 393–402, 2003. View at Google Scholar · View at Scopus
  16. M. R. D'Andrea, G. M. Cole, and M. D. Ard, “The microglial phagocytic role with specific plaque types in the Alzheimer disease brain,” Neurobiology of Aging, vol. 25, no. 5, pp. 675–683, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Viña, A. Lloret, R. Ortí, and D. Alonso, “Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress,” Molecular Aspects of Medicine, vol. 25, no. 1-2, pp. 117–123, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. C. Polidori, P. Mattioli, S. Aldred et al., “Plasma antioxidant status, immunoglobulin G oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia,” Dementia and Geriatric Cognitive Disorders, vol. 18, no. 3-4, pp. 265–270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. C. Conrad, P. L. Marshall, J. M. Talent, C. A. Malakowsky, J. Choi, and R. W. Gracy, “Oxidized proteins in Alzheimer's plasma,” Biochemical and Biophysical Research Communications, vol. 275, no. 2, pp. 678–681, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Choi, C. A. Malakowsky, J. M. Talent, C. C. Conrad, and R. W. Gracy, “Identification of oxidized plasma proteins in Alzheimer's disease,” Biochemical and Biophysical Research Communications, vol. 293, no. 5, pp. 1566–1570, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Heseker and R. Schneider, “Requirement and supply of vitamin C, E and β-carotene for elderly men and women,” European Journal of Clinical Nutrition, vol. 48, no. 2, pp. 118–127, 1994. View at Google Scholar · View at Scopus
  22. R. Stocker and B. Frei, “Endogenous antioxidant defences in human blood plasma,” in Oxidative Stress: Oxidants and Antioxidants, H. Sies, Ed., Academic Press, London, UK, 1991. View at Google Scholar
  23. K. F. Gey, “Prevention of early stages of cardiovascular disease and cancer may require concurrent optimization of all major antioxidants and other nutrients, an update and reevaluation of observational data and intervention trials,” in Free Radicals, Lipoprotein Oxidation and Atherosclerosis, C. Rice-Evans, Ed., Richelieu Press, London, UK, 1995. View at Google Scholar
  24. C. Behl and B. Moosmann, “Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach,” Free Radical Biology and Medicine, vol. 33, no. 2, pp. 182–191, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Esposito, D. Rotilio, V. di Matteo, C. di Giulio, M. Cacchio, and S. Algeri, “A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes,” Neurobiology of Aging, vol. 23, no. 5, pp. 719–735, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Mecocci, M. Cristina Polidori, A. Cherubini et al., “Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease,” Archives of Neurology, vol. 59, no. 5, pp. 794–798, 2002. View at Google Scholar · View at Scopus
  27. M. Sano, “Do dietary antioxidants prevent Alzheimer's disease?” The Lancet Neurology, vol. 1, no. 6, p. 342, 2002. View at Google Scholar · View at Scopus
  28. S. S. Chan, H. P. Monteiro, F. Schindler, A. Stern, and V. B. C. Junqueira, “α-tocopherol modulates tyrosine phosphorylation in human neutrophils by inhibition of protein kinas C activity and activation of tyrosine phosphatases,” Free Radical Research, vol. 35, no. 6, pp. 843–856, 2001. View at Google Scholar · View at Scopus
  29. E. M. Bulger and R. V. Maier, “An argument for vitamin E supplementation in the management of systemic inflammatory response syndrome,” Shock, vol. 19, no. 2, pp. 99–103, 2003. View at Google Scholar · View at Scopus
  30. P. P. Zandi, J. C. Anthony, A. S. Khachaturian et al., “Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County study,” Archives of Neurology, vol. 61, no. 1, pp. 82–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Kusdra, H. Rempel, K. Yaffe, and L. Pulliam, “Elevation of CD69+ monocyte/macrophages in patients with Alzheimer's disease,” Immunobiology, vol. 202, no. 1, pp. 26–33, 2000. View at Google Scholar · View at Scopus
  32. J. A. Casal, A. Robles, and J. C. Tutor, “Serum markers of monocyte/macrophage activation in patients with Alzheimer's disease and other types of dementia,” Clinical Biochemistry, vol. 36, no. 7, pp. 553–556, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. C. K. Combs, J. Colleen Karlo, S.-C. Kao, and G. E. Landreth, “β-amyloid stimulation of microglia anti monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis,” Journal of Neuroscience, vol. 21, no. 4, pp. 1179–1188, 2001. View at Google Scholar · View at Scopus
  34. Y. Beloosesky, H. Salman, M. Bergman, H. Bessler, and M. Djaldetti, “Cytokine levels and phagocytic activity in patients with Alzheimer's disease,” Gerontology, vol. 48, no. 3, pp. 128–132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Shalit, B. Sredni, L. Stern, E. Kott, and M. Huberman, “Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients,” Neuroscience Letters, vol. 174, no. 2, pp. 130–132, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Azzi, R. Gysin, P. Kempná et al., “The role of α-tocopherol in preventing disease: from epidemiology to molecular events,” Molecular Aspects of Medicine, vol. 24, no. 6, pp. 325–336, 2003. View at Publisher · View at Google Scholar · View at Scopus